SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000929638-24-001326
Filing Date
2024-04-03
Accepted
2024-04-03 17:01:40
Documents
13
Period of Report
2024-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 a8k.htm   iXBRL 8-K 20841
  Complete submission text file 0000929638-24-001326.txt   145212

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adxs-20240325.xsd EX-101.SCH 3856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adxs-20240325_lab.xml EX-101.LAB 20046
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adxs-20240325_pre.xml EX-101.PRE 14629
16 EXTRACTED XBRL INSTANCE DOCUMENT a8k_htm.xml XML 3774
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36138 | Film No.: 24819829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)